Haemonetics | HAE - Current Assets


Haemonetics reported $834.88M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Avanos Medical USD 325M 30.4M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
Cerus USD 174.38M 7.26M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Haemonetics USD 834.88M 108.8M Mar/2026
ICU Medical USD 1.21B 22.69M Mar/2026
Intuitive Surgical USD 11.52B 881.5M Mar/2026
Masimo USD 870.5M 55.5M Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.1B 61.62M Mar/2026
Neogen USD 590M 15.42M Dec/2025
OraSure Technologies USD 240.78M 21.13M Mar/2026
Plus Therapeutics USD 18.03M 2.86M Mar/2026
Quidel USD 1.38B 70.3M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
STAAR Surgical USD 312.4M 853K Mar/2026
Steris USD 2.39B 108.4M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Surmodics USD 75.99M 5.31M Jun/2025
Teleflex USD 1.86B 78.67M Mar/2026
Terumo JPY 861.04B 45.48B Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
US Physical Therapy USD 139.11M 881K Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026